Mechanistic studies further revealed that melatonin mediates the degradation of death-associated protein kinase 1 (DAPK1) and enhances the activity of Pin1, a prolyl isomerase with a protective role against tau hyperphosphorylation and tau-related pathology in AD [76]. The gene discussed is MAPT; the disease is Alzheimer disease.